[Federal Register: March 25, 2009 (Volume 74, Number 56)]
[Notices]
[Page 12873]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25mr09-112]
[[Page 12873]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Pilot Lifestyle Interventions for Pregestational
Diabetes or Gestational Diabetes, PEP 2009-R-01/02
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned meeting.
Time and Date: 1 p.m.-4 p.m., May 20, 2009 (Closed).
1 p.m.-4 p.m., May 21, 2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the review,
discussion, and evaluation of ``Pilot Lifestyle Interventions for
Pregestational Diabetes or Gestational Diabetes, PEP 2009-R-01/02.''
Contact Person for More Information: Linda Shelton, Program
Specialist, Coordinating Center for Health and Information Service,
Office of the Director, CDC, 1600 Clifton Road, NE., Mailstop E21,
Atlanta, GA 30333, Telephone (404) 498-1194.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both CDC and the Agency for Toxic Substances and
Disease Registry.
Dated: March 16, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. E9-6715 Filed 3-24-09; 8:45 am]
BILLING CODE 4163-18-P